Stroke and death risk in ventricular assist device patients varies by ISHLT infection category: An INTERMACS analysis.

Autor: Shah P; Department of Heart Failure and Transplantation, Inova Heart and Vascular Institute, Falls Church, Virginia, USA. Electronic address: palak.shah@inova.org., Birk SE; School of Public Health, George Washington University, Washington, DC, USA., Cooper LB; Department of Heart Failure and Transplantation, Inova Heart and Vascular Institute, Falls Church, Virginia, USA; Department of Medicine, Duke University, Durham, North Carolina, USA., Psotka MA; Department of Heart Failure and Transplantation, Inova Heart and Vascular Institute, Falls Church, Virginia, USA., Kirklin JK; Department of Cardiac Surgery, University of Alabama, Birmingham, Alabama, USA., Barnett SD; Department of Heart Failure and Transplantation, Inova Heart and Vascular Institute, Falls Church, Virginia, USA., Katugaha SB; Infectious Diseases Physicians, Inc., Phillips S; Department of Heart Failure and Transplantation, Inova Heart and Vascular Institute, Falls Church, Virginia, USA., Looby MM; Cardiovascular Pharmacy, Inova Heart and Vascular Institute, Falls Church, Virginia, USA., Pagani FD; Department of Cardiac Surgery, University of Michigan, Ann Arbor, Michigan, USA., Cowger JA; Department of Heart Failure and Transplantation, Henry Ford Medical Center, Detroit, Michigan, USA.

Publikováno v: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation [J Heart Lung Transplant] 2019 Jul; Vol. 38 (7), pp. 721-730. Date of Electronic Publication: 2019 Feb 12.